Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pathological Myopic Choroidal Neovascularization”

35 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 35 results

Post-approval studies (Phase 4)Study completedNCT03042871
What this trial is testing

Dosing Strategy of Intravitreal Ranibizumab for Pathological Myopia Choroidal Neovascularization

Who this might be right for
Choroidal Neovascularization
Zhongshan Ophthalmic Center, Sun Yat-sen University 54
Not applicableUnknownNCT04488887
What this trial is testing

OCTA Metrics Repeatability and Reproducibility in Different Disorders

Who this might be right for
Diabetic RetinopathyMyopiaChoroidal Neovascularization+1 more
Tanta University 80
Not applicableNot Yet RecruitingNCT06918028
What this trial is testing

An Interpretable Fundus Diseases Report Generating System Based On Weakly Labelings

Who this might be right for
Retinal DiseasesChoroidal DiseasePathological Myopia+3 more
Zhongshan Ophthalmic Center, Sun Yat-sen University 9,999
Not applicableStudy completedNCT04524910
What this trial is testing

Learn More About How Drug Aflibercept Works in Canadian Patients With Reduced Vision Caused by New Blood Vessels Growing in the Eye (Myopic Choroidal Neovascularization or mCNV)

Who this might be right for
Myopic Choroidal Neovascularization
Bayer 28
Testing effectiveness (Phase 2)Study completedNCT00470977
What this trial is testing

Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy

Who this might be right for
Coats' DiseaseIdiopathic Retinal TelangiectasiaRetinal Angiomatous Proliferation+7 more
Manhattan Eye, Ear & Throat Hospital 18
Testing effectiveness (Phase 2)UnknownNCT04922151
What this trial is testing

601 Versus Ranibizumab in Patients With Pathological Myopic Choroidal Neovascularization (pmCNV)

Who this might be right for
Pathological Myopic Choroidal Neovascularization
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 60
Not applicableWithdrawnNCT01218230
What this trial is testing

Intravitreal Pegaptanib in Treatment of Choroidal Neovascularisation Secondary to Pathologic Myopia

Who this might be right for
Myopic Choroidal Neovascular Membrane
L.V. Prasad Eye Institute
Not applicableStudy completedNCT03963596
What this trial is testing

Antiangiogenic Therapy of Choroidal Neovascularisation Associated With Myopia

Who this might be right for
Pathologic Myopia
The Filatov Institute of Eye Diseases and Tissue Therapy 122
Post-approval studies (Phase 4)Study completedNCT00797992
What this trial is testing

Bevacizumab Intravitreal for Myopic Choroidal Neovascularization

Who this might be right for
Myopic Choroidal Neovascularization
Instituto de Olhos de Goiania 5
Large-scale testing (Phase 3)Study completedNCT01249664
What this trial is testing

VEGF Trap-Eye in Choroidal Neovascularization Secondary to Pathologic Myopia (mCNV)

Who this might be right for
Myopia, Pathological
Bayer 122
Testing effectiveness (Phase 2)Study completedNCT01037348
What this trial is testing

Ranibizumab for the Treatment of Choroidal Neovascularisation (CNV) Secondary to Pathological Myopia (PM): an Individualized Regimen

Who this might be right for
Choroidal Neovascularisation
Novartis 65
Not applicableStudy completedNCT05677685
What this trial is testing

VISUPRIME® Eye Drops

Who this might be right for
Macular Degeneration, Age RelatedMyopic Choroidal NeovascularisationProliferative Diabetic Retinopathy+2 more
VISUfarma SpA 78
Not applicableNot Yet RecruitingNCT07009574
What this trial is testing

The Treatment Burden of Myopic Choroidal Neovascularization

Who this might be right for
Myopic Choroidal NeovascularisationAnti-VEGF TreatmentBurden
Policlinico Gaspare Rodolico - San Marco Catania 100
Early research (Phase 1)Study completedNCT00802126
What this trial is testing

Intravitreal Bevacizumab and Low Fluence Photodynamic Therapy

Who this might be right for
Myopia
University of Campania Luigi Vanvitelli 16
Large-scale testing (Phase 3)Study completedNCT01217944
What this trial is testing

Efficacy and Safety of Ranibizumab in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia

Who this might be right for
Pathological Myopia
Novartis Pharmaceuticals 277
Not applicableUnknownNCT05494775
What this trial is testing

Effect of Corona Virus on Intravitreal Injections

Who this might be right for
Diabetic Macular EdemaAge-Related Macular DegenerationChoroidal Neovascularization+2 more
Benha University 250
Not applicableStudy completedNCT02260687
What this trial is testing

Special Drug Use Investigation of EYLEA for Myopic Choroidal Neovascularization

Who this might be right for
Choroidal Neovascularization
Bayer 353
Large-scale testing (Phase 3)Study completedNCT00967850
What this trial is testing

Efficacy and Safety of Intravitreal Bevacizumab in the Treatment of Choroidal Neovascular Membranes Associated to High Myopia

Who this might be right for
MyopiaChoroidal Neovascularization
Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA 56
Large-scale testing (Phase 3)Study completedNCT00370786
What this trial is testing

Effect of Intravitreal Bevacizumab on Non -Age-Related Macular Degeneration (AMD) Related Choroidal Neovascularization (CNV)

Who this might be right for
Choroidal Neovascularization
Shahid Beheshti University of Medical Sciences 31
Large-scale testing (Phase 3)Study completedNCT01922102
What this trial is testing

Efficacy and Safety of Ranibizumab 0.5 vs Verteporfin PDT in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia

Who this might be right for
Visual Impairment Due to Choroidal Neovascularization (CNV) Secondary to Pathologic Myopia (PM)
Novartis Pharmaceuticals 457
Load More Results